Financhill
Back

Solid Biosciences Quote, Financials, Valuation and Earnings

Solid Biosciences Price Quote

$5.42
-0.14 (-2.52%)
(Updated: November 14, 2024 at 11:40 AM ET)

Solid Biosciences Key Stats

Sell
17
Solid Biosciences (SLDB) is a Sell

Day range:
$5.42 - $5.87
52-week range:
$2.10 - $15.05
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
13.12
P/B ratio:
1.32%

Volume:
291.3K
Avg. volume:
318.6K
1-year change:
157.41%
Market cap:
$220.1M
Revenue:
$0
EPS:
$-3.04

How Much Does Solid Biosciences Make?

Data Unavailable

Is Solid Biosciences Growing As A Company?

Data Unavailable

Solid Biosciences Stock Price Performance

What Is Solid Biosciences 52-Week High & Low?

Solid Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Solid Biosciences?

  • How Much Debt Does Solid Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Solid Biosciences Have?
    Cash and short term investments quarterly total is $171.1M
  • What Is Solid Biosciences’s Book Value Per Share?
    Book value per share is 4.29

Is Solid Biosciences Cash Flow Positive?

  • What Is SLDB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$91.2M
  • What Is Solid Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $116M
  • What Is Solid Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$9.4M

Solid Biosciences Return On Invested Capital

Data Unavailable

Solid Biosciences Earnings Date & Stock Price

Solid Biosciences Competitors

  • Who Are Solid Biosciences's Competitors?
    Below is a list of companies who compete with Solid Biosciences or are related in some way:
    • Perspective Therapeutics Inc (CATX)
    • Electromed Inc (ELMD)
    • Myomo Inc (MYO)
    • Catheter Precision Inc (VTAK)
    • Xtant Medical Holdings Inc (XTNT)

Solid Biosciences Dividend Yield

Solid Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -20.3%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 17.43
Upside from Last Price: 213.46%

Major Shareholders

  • How many SLDB shares are owned by institutional investors?
    46.1M SLDB shares are owned by institutional investors
  • How many SLDB shares are owned by insiders?
    8.1M SLDB shares are owned by insiders